{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:12:42Z","timestamp":1791238362392,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Thrombophilia is a coagulation disorder closely associated with venous thromboembolism. Hereditary antithrombin III (AT III) deficiency is a type of genetic thrombophilia. In China, genetic thrombophilia patients mainly suffer from deficiencies in AT III, protein S, and protein C. Multiple mutations in the serpin family C member 1 (<jats:italic toggle=\"yes\">SERPINC1<\/jats:italic>) can affect AT III activity, resulting in thrombosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>This case presented a 17-year-old adolescent female who developed lower extremity venous thrombosis and subsequently pulmonary embolism (PE) following a right leg injury. A missense mutation in gene <jats:italic toggle=\"yes\">SERPINC1<\/jats:italic> of c.331 T\u2005&gt;\u2005C, p.S111P was detected on the patient, resulting in a decreased AT III activity and an elevated risk of thrombosis. The patient received anticoagulation treatment for approximately 5 months. During follow-up, the blood clot gradually dissolved, and there have been no recurrent thrombotic events reported thus far.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion:<\/jats:title>\n            <jats:p>Hereditary AT deficiency can be classified into two types based on the plasma levels of the enzymatic activity and antigen. Type I is a quantitative defect, while Type II is a qualitive defect. Until 2021, 486 <jats:italic toggle=\"yes\">SERPINC1<\/jats:italic> gene mutations have been registered, more than 18% of which are point mutations. The <jats:italic toggle=\"yes\">SERPINC1<\/jats:italic> mutation c.331 T\u2005&gt;\u2005C in was firstly reported in 2017, which was classified into type I AT III deficiency.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Hereditary thrombophilia is a coagulation disorder with a high omission diagnostic rate. Minor mutations in the <jats:italic toggle=\"yes\">SERPINC1<\/jats:italic> gene can also lead to hereditary AT III deficiency, which in turn can cause PE. We emphasized the importance of etiological screening for hereditary thrombophilia in venous thromboembolism patients without obvious high-risk factors. Long-term anticoagulation treatment and avoidance of potential thrombosis risk factors are critical for such patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037429","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:04:18Z","timestamp":1709928258000},"page":"e37429","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary thromboembolism associated with hereditary antithrombin III deficiency: A case report"],"prefix":"10.1097","volume":"103","author":[{"given":"Jingwei","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Rong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoguo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9616-9633","authenticated-orcid":false,"given":"Weihua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First Hospital of Jilin University, Changchun, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","first-page":"44","article-title":"Hereditary thrombophilia.","volume":"90","author":"Dautaj","year":"2019","journal-title":"Acta Biomed"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/jhm.2616","article-title":"Inpatient inherited thrombophilia testing.","volume":"11","author":"Petrilli","year":"2016","journal-title":"J Hosp Med"},{"key":"R3-20250503","first-page":"881","article-title":"Chinese guidelines for diagnosis, prevention and treatment of thrombophilia (2021).","volume":"42","year":"2021","journal-title":"Chin J Hematol"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181faa0f2","article-title":"Factor V Leiden thrombophilia.","volume":"13","author":"Kujovich","year":"2011","journal-title":"Genet Med"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1160\/TH16-08-0635","article-title":"Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency.","volume":"117","author":"Alhenc-Gelas","year":"2017","journal-title":"Thromb Haemost"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/17474086.2019.1583555","article-title":"Thrombophilia, risk factors and prevention.","volume":"12","author":"Campello","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jth.15140","article-title":"Ethnoracial variations in venous thrombosis: implications for management, and a call to action.","volume":"19","author":"Xu","year":"2021","journal-title":"J Thromb Haemost"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-0032-1315758","article-title":"Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature.","volume":"38","author":"Dentali","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17474086.2019.1611424","article-title":"Management of antithrombin deficiency: an update for clinicians.","volume":"12","author":"Bravo-P\u00e9rez","year":"2019","journal-title":"Expert Rev Hematol"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/ijms23031821","article-title":"Inherited thrombophilia in the era of direct oral anticoagulants.","volume":"23","author":"Khider","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R11-20250503","first-page":"141","article-title":"Deficiency of antithrombin III (AT III)\u2013case report and review of the literature.","volume":"40","author":"G\u0103man","year":"2014","journal-title":"Curr Health Sci J"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2165\/00003495-200767100-00005","article-title":"Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options.","volume":"67","author":"Maclean","year":"2007","journal-title":"Drugs"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2141.1994.tb04878.x","article-title":"Prevalence of antithrombin deficiency in the healthy population.","volume":"87","author":"Tait","year":"1994","journal-title":"Br J Haematol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","article-title":"Inherited antithrombin deficiency: a review.","volume":"14","author":"Patnaik","year":"2008","journal-title":"Haemophilia"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/bjh.14658","article-title":"SERPINC1 gene mutations in antithrombin deficiency.","volume":"178","author":"Mulder","year":"2017","journal-title":"Br J Haematol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.thromres.2020.02.025","article-title":"Seventeen novel SERPINC1 variants causing hereditary antithrombin deficiency in a Czech population.","volume":"189","author":"Provaznikova","year":"2020","journal-title":"Thromb Res"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2019.01.022","article-title":"SERPINC1 variants causing hereditary antithrombin deficiency in a Danish population.","volume":"175","author":"Kjaergaard","year":"2019","journal-title":"Thromb Res"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.thromres.2019.04.004","article-title":"Molecular basis of SERPINC1 mutations in Japanese patients with antithrombin deficiency.","volume":"178","author":"Tamura","year":"2019","journal-title":"Thromb Res"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1111\/ijlh.13097","article-title":"A novel SERPINC1 frameshift mutation in two antithrombin deficiency families.","volume":"42","author":"Zhang","year":"2020","journal-title":"Int J Lab Hematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:22:08Z","timestamp":1746318128000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037429","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,8]]}}}